Indeed, treatment of type 2 diabetes with GLP-1 receptor agonists, including FDA-approved exenatide and liraglutide, have demonstrated significant reductions in hyperglycemia, haemoglobin A1c, and body weight 19
Tognini P, Murakami M, Liu Y, Eckel-Mahan KL, Newman JC, Verdin E, et al
In other studies, Mounjaro helped people lose 12 to 15 pounds on a 5-mg weekly dose, between 15 and 21 pounds on a 10-mg weekly dose, and between 17 and 25 pounds on a 15-mg weekly dose
Additionally, its potentially beneficial for those dealing with conditions related to weight, such as type 2 diabetes or high cholesterol
Mid-term safety and efficacy of magnesium bioresorbable vascular scaffolds-magmaris in diabetic population
Scumpia says: We now have strong evidence that reducing visceral fat improves testosterone without jumping to hormone therapy